MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.leukres.2019.05.009

Медицинская библиотека · Leukemia research · 2019

Prognostic gene alterations and clonal changes in childhood B-ALL.

Erbilgin Yucel, Firtina Sinem, Mercan Sevcan, Hatirnaz Ng Ozden, Karaman Serap, Tasar Orcun, Karakas Zeynep, Celkan Tulin Tiraje, Zengin Emine, Sarper Nazan, Yildirmak Zeynep Yildiz, Sisko Sinem, Ozbek Ugur, Sayitoglu Muge

Клиническое исследованиеСтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Genomic profiles of leukemia patients lead to characterization of variations that provide the molecular classification of risk groups, prediction of clinical outcome and therapeutic decisions. In this study, we examined the diagnostic (n = 77) and relapsed (n = 31) pediatric B-cell acute lymphoblastic leukemia (B-ALL) samples for the most common leukemia-associated gene variations CRLF2, JAK2, PAX5 and IL7R using deep sequencing and copy number alterations (CNAs) (CDKN2A/2B, PAX5, RB1, BTG1, ETV6, CSF2RA, IL3RA and CRLF2) by multiplex ligation proximity assay (MLPA), and evaluated for the clonal changes through relapse. Single nucleotide variations SNVs were detected in 19% of diagnostic 15.3% of relapse samples. The CNAs were detected in 55% of diagnosed patients; most common affected genes were CDKN2A/2B, PAX5, and CRLF2. Relapse samples did not accumulate a greater number of CNAs or SNVs than the cohort of diagnostic samples, but the clonal dynamics showed the accumulation/disappearance of specific gene variations explained the course of relapse. The CDKN2A/2B were most frequently altered in relapse samples and 32% of relapse samples carried at least one CNA. Moreover, CDKN2A/2B alterations and/or JAK2 variations were associated with decreased relapse-free survival. On the other hand, CRLF2 copy number alterations predicted a better survival rate in B-ALL. These findings contribute to the knowledge of CDKN2A/2B and CRLF2 alterations and their prognostic value in B-ALL. The integration of genomic data in clinical practice will enable better stratification of ALL patients and allow deeper understanding of the nature of relapse.

Для цитирования: Erbilgin Yucel, Firtina Sinem, Mercan Sevcan, Hatirnaz Ng Ozden, Karaman Serap, Tasar Orcun, Karakas Zeynep, Celkan Tulin Tiraje, Zengin Emine, Sarper Nazan, Yildirmak Zeynep Yildiz, Sisko Sinem, Ozbek Ugur, Sayitoglu Muge. Prognostic gene alterations and clonal changes in childhood B-ALL.. Leukemia research. 2019. DOI: 10.1016/j.leukres.2019.05.009.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.